Salicylic acid

Description

Premier Maximum Strength Wart Remover Fast Acting Gel is formulated to effectively remove common and plantar warts. This product features a no-drip formula, ensuring ease of application. It is designed for safety and efficacy in wart removal. The net weight of the gel is 0.25 ounces (7 grams).

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting tenderness and disrupting the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

After washing the affected area, the wart should be soaked in comfortably warm water for 5 minutes. Following this, the area must be dried thoroughly. A drop of gel should then be gently squeezed from the tube and applied directly to the wart, ensuring that one drop is used at a time to sufficiently cover each wart. It is important to allow the area to dry after application.

This procedure should be repeated once or twice daily until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

• In patients with diabetes or poor blood circulation, unless under the advice and supervision of a healthcare professional.

• On moles, birthmarks, or warts with hair growth.

• On mucous membranes, including the nose, anus, genitals, and lips.

• On irritated, infected, or reddened skin.

• On genital warts and facial warts.

In the event of accidental exposure to the eyes, it is essential to flush with water for 15 minutes. Inhalation of vapors should be avoided. This product should be kept out of reach of children; if ingested, immediate medical assistance or contact with a Poison Control Center is required.

Warnings and Precautions

For external use only, this product is flammable and should be kept away from fire and flame. It is contraindicated for use in individuals with diabetes or poor blood circulation unless under the advice and supervision of a qualified healthcare professional, such as a doctor or podiatrist.

This product must not be applied to moles, birthmarks, or warts with hair growing from them, nor should it be used on mucous membranes, including the nose, anus, genitals, and lips. Additionally, it should not be applied to irritated, infected, or reddened skin, nor on genital warts or warts located on the face.

While using this product, if it comes into contact with the eyes, it is imperative to flush the eyes with water for at least 15 minutes. Users should also avoid inhaling vapors associated with the product. Should discomfort persist after application, it is advisable to consult a doctor or podiatrist for further evaluation.

This product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients should be aware that this product is intended for external use only. It is contraindicated for individuals who are diabetic or have poor blood circulation, unless under the advice and supervision of a healthcare professional, such as a doctor or podiatrist.

The product should not be applied to moles, birthmarks, or warts with hair growing from them, nor should it be used on mucous membranes, including the nose, anus, genitals, and lips. Additionally, it is not recommended for use on irritated, infected, or reddened skin, as well as genital warts and warts located on the face.

During the use of this product, if it comes into contact with the eyes, it is essential to flush the eyes with water for at least 15 minutes. Users should also avoid inhaling vapors associated with the product.

In the event that discomfort persists, patients are advised to consult their doctor or podiatrist. If the product is ingested, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

The use of this medication is contraindicated in individuals with diabetes or poor blood circulation, unless prescribed and monitored by a qualified healthcare professional, such as a doctor or podiatrist.

No specific drug or laboratory test interactions have been identified in the available data. Therefore, routine monitoring or dosage adjustments related to drug interactions are not necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Remover Gel. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of this product during pregnancy has not been established. This product is contraindicated in pregnancy due to potential risks to the fetus. Pregnant patients or those planning to become pregnant should consult a healthcare provider before use to discuss potential risks and benefits.

Lactation

Nursing mothers should consult a healthcare professional before using this product. There is a potential for excretion in breast milk, and the safety of this product during lactation has not been established. Caution is advised when using this product while breastfeeding.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that if discomfort persists, they should consult their doctor or podiatrist for further evaluation.

Instruct patients to flush their eyes with water for at least 15 minutes if the product comes into contact with them. Additionally, healthcare providers should emphasize the importance of avoiding inhalation of vapors associated with the product.

Patients should be cautioned against using the product if they are diabetic or have poor blood circulation, unless they are under the advice and supervision of a qualified healthcare professional. It is also critical to inform patients not to apply the product on moles, birthmarks, or warts that have hair growing from them, as well as to avoid application on mucous membranes, including the nose, anus, genitals, and lips.

Furthermore, healthcare providers should advise patients not to use the product on irritated, infected, or reddened skin, and to refrain from using it on genital warts and warts located on the face.

Storage and Handling

The product is supplied in various configurations, with specific NDC numbers available for identification. It is essential to store the product in a controlled environment, maintaining a temperature range between 59°F to 86°F (15°C to 30°C).

Additionally, it is crucial to keep the product away from fire and flame to ensure safety and integrity. Proper handling and storage conditions must be adhered to in order to maintain the quality and efficacy of the product.

Additional Clinical Information

Patients should be advised to consult their doctor or podiatrist if discomfort persists. In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately. No further information is available regarding laboratory tests, abuse potential, or the route, method, and frequency of administration. Additionally, there are no updates from postmarketing experience.

Drug Information (PDF)

This file contains official product information for Wart Remover Gel, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)